科瑞技術(002957.SZ):公司的疊片技術,在疊片效率和對齊精度等方面均處於行業領先水平
格隆匯3月31日丨科瑞技術(002957.SZ)在投資者互動平台表示,在新能源領域,公司定位於新能源鋰電製造設備行業中後段解決方案提供商,聚焦行業頭部客户的需求,是裸電芯製作、電芯裝配段、化成分容設備的領先供應商。公司的疊片、包藍膜、方鋁裝配整線、激光焊接、化成分容等生產設備,廣泛應用於各類消費電池和動力電池領域,技術和性能處於業內領先水平,是相關設備的領先供應商。其中,公司的疊片技術,在疊片效率和對齊精度等方面均處於行業領先水平;公司的化成分容裝備,產品系列豐富,產品質量和技術能力獲得行業頭部客户的持續認可與好評。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.